• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Karyopharm Therapeutics Inc. - Common Stock (NQ:KPTI)

8.160 +0.100 (+1.24%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 294,996
Open 8.070
Bid (Size) 6.750 (100)
Ask (Size) 9.000 (1,000)
Prev. Close 8.060
Today's Range 7.995 - 8.420
52wk Range 3.650 - 10.99
Shares Outstanding 114,010,448
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Karyopharm (KPTI) Q1 2026 Earnings Transcript ↗
May 14, 2026
Karyopharm (KPTI) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
Karyopharm Therapeutics Q1 Earnings Call Highlights ↗
May 14, 2026
Karyopharm Therapeutics (NASDAQ:KPTI) said it entered 2026 with several near-term clinical and regulatory catalysts, led by new Phase 3 data in myelofibrosis and an expected midyear readout in... 
Via MarketBeat
Topics Earnings

Performance

YTD
+13.5%
+13.5%
1 Month
-6.7%
-6.7%
3 Month
-18.6%
-18.6%
6 Month
+46.8%
+46.8%
1 Year
+77.8%
+77.8%

More News

Read More
Karyopharm Therapeutics Inc (NASDAQ:KPTI) Posts Q1 Beat and Highlights ASCO Presentation, Shares Surge 7% ↗
May 14, 2026
Via Chartmill
News headline image
Karyopharm (KPTI) Q2 2025 Earnings Transcript ↗
May 04, 2026
Via The Motley Fool
Karyopharm Therapeutics Inc (NASDAQ:KPTI) Reports Q4 Revenue Miss and Wider Loss, Stock Falls in Pre-Market ↗
February 12, 2026
Via Chartmill
News headline image
Earnings Scheduled For November 3, 2025 ↗
November 03, 2025
Via Benzinga
News headline image
Karyopharm Therapeutics Earnings Preview ↗
October 31, 2025
Via Benzinga
News headline image
Karyopharm (KPTI) Q1 2025 Earnings Transcript ↗
May 04, 2026
Via The Motley Fool
News headline image
Registration Momentum Builds Across the Oncology Pipeline
February 17, 2026
From USA News Group
Via GlobeNewswire
News headline image
Karyopharm (KPTI) Q4 2025 Earnings Call Transcript ↗
February 12, 2026
Via The Motley Fool
Topics Derivatives Earnings
News headline image
Earnings Outlook For Karyopharm Therapeutics ↗
August 08, 2025
Via Benzinga
News headline image
Earnings Scheduled For May 12, 2025 ↗
May 12, 2025
Via Benzinga
News headline image
Karyopharm Therapeutics Inc (NASDAQ:KPTI) Reports Q3 2025 Revenue Beat and Earnings Miss ↗
November 03, 2025
Via Chartmill
Topics Earnings
News headline image
This Palo Alto Networks Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗
October 13, 2025
Via Benzinga
News headline image
Karyopharm Strengthens Balance Sheet With $100 Million Financing To Extend Cash Runway Into 2026 ↗
October 08, 2025
Via Benzinga
News headline image
These stocks that are showing activity before the opening bell on Wednesday. ↗
October 08, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
October 08, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
September 24, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
September 23, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
September 08, 2025
Via Benzinga
News headline image
Top movers analysis in the middle of the day on 2025-08-15: top gainers and losers in today's session. ↗
August 15, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
July 11, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
July 11, 2025
Via Benzinga
News headline image
These Analysts Revise Their Forecasts On Karyopharm Therapeutics After Q1 Results ↗
May 13, 2025
Via Benzinga
News headline image
Earnings Scheduled For August 11, 2025 ↗
August 11, 2025
Via Benzinga

Frequently Asked Questions

Is Karyopharm Therapeutics Inc. - Common Stock publicly traded?
Yes, Karyopharm Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Karyopharm Therapeutics Inc. - Common Stock trade on?
Karyopharm Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Karyopharm Therapeutics Inc. - Common Stock?
The ticker symbol for Karyopharm Therapeutics Inc. - Common Stock is KPTI on the Nasdaq Stock Market
What is the current price of Karyopharm Therapeutics Inc. - Common Stock?
The current price of Karyopharm Therapeutics Inc. - Common Stock is 8.160
When was Karyopharm Therapeutics Inc. - Common Stock last traded?
The last trade of Karyopharm Therapeutics Inc. - Common Stock was at 05/22/26 04:00 PM ET
What is the market capitalization of Karyopharm Therapeutics Inc. - Common Stock?
The market capitalization of Karyopharm Therapeutics Inc. - Common Stock is 930.33M
How many shares of Karyopharm Therapeutics Inc. - Common Stock are outstanding?
Karyopharm Therapeutics Inc. - Common Stock has 930M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap